Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21WAF1 expression

Experimental Cell Research

Volumn 285, Issue 2, 2003, Pages 236-242

  Wyllie, Fiona ^a   Haughton, Michele ^a   Bartek, Jiri ^b   Rowson, Jan ^a   Wynford Thomas, David ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cdk2; Cell cycle; P21; P53; Replicative senescence

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; M PROTEIN; MUTANT PROTEIN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GROWTH DISORDER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENESCENCE; UPREGULATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 0037403348     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00050-8     Document Type: Article

References (35)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:1965;614-636.
2. Wright W.E., Pereira-Smith O.M., Shay J.W. Reversible cellular senescence implications for immortalization of normal human diploid fibroblasts . Mol. Cell Biol. 9:1989;3088-3092.
3. Bryan T.M., Reddel R.R. SV40-induced immortalization of human cells. Crit. Rev. Oncol. 5:1994;331-357.
4. Shay J.W., Wright W.E., Brasiskyte D., Van der Haegen B.A. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene. 8:1993;1407-1413.
5. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
6. Stein G.H., Beeson M., Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science. 249:1998;666-669.
7. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA. 93:1996;13742-13747.
8. Hara E., Smith R., Parry D., Tahara H., Stone S., Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell Biol. 16:1996;859-867.
9. Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., Smith J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:1994;90-98.
10. Brown J.P., Wei W., Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 277:1999;831-834.
11. el-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
12. Slebos R.J., Lee M.H., Plunkett B.S., Kessis T.D., Williams B.O., Jacks T., Hedrick L., Kastan M.B., Cho K.R. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;5320-5324.
13. Bacchetti S. Telomere dynamics and telomerase activity in cell senescence and cancer. Cell Dev. Biol. 7:1996;31-39.
14. Bond J.A., Haughton M.F., Rowson J.M., Smith P.J., Gire V., Wynford-Thomas D., Wyllie F.S. Control of replicative life span in human cells barriers to clonal expansion intermediate between M1 senescence and M2 crisis . Mol. Cell Biol. 19:1999;3103-3114.
15. Gire V., Wynford-Thomas D. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol. Cell Biol. 18:1998;1611-1621.
16. Bond J.A., Wyllie F.S., Wynford-Thomas D. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene. 9:1994;1885-1889.
17. Bond J.A., Blaydes J.P., Rowson J., Haughton M.F., Smith J.R., Wynford-Thomas D., Wyllie F.S. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res. 55:1995;2404-2409.
18. Rubelj I., Pereira-Smith O.M. SV40-transformed human cells in crisis exhibit changes that occur in normal cellular senescence. Exp. Cell Res. 211:1994;82-89.
19. Tahara H., Sato E., Noda A., Ide T. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal, and SV40-transformed human fibroblasts. Oncogene. 10:1995;835-840.
20. Friedlander P., Haupt Y., Prives C., Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell Biol. 16:1996;4961-4971.
21. Ludwig R.L., Bates S., Vousden K.H. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell Biol. 16:1996;4952-4960.
22. Wyllie F.S., Lemoine N.R., Barton C.M., Dawson T., Bond J.A., Wynford-Thomas D. Direct growth stimulation of normal human epithelial cells by mutant p53. Mol. Carcinogen. 7:1993;83-88.
23. Lukas J., Pagano M., Staskova Z., Draetta G., Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene. 9:1994;707-718.
24. Kitagawa M., Higashi H., Jung H.K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshida E., Nishimura S., Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:1996;7060-7069.
25. Alessi F., Quarta S., Savio M., Riva F., Rossi L., Stivala L.A., Scovassi A.I., Meijer L., Prosperi E. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp. Cell Res. 245:1998;8-18.
26. Stein G.H., Drullinger L.F., Soulard A., Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell Biol. 19:1999;2109-2117. [in process citation].
27. Polyak K., Waldman T., He T.C., Kinzler K.W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1996;1945-1952.
28. Slingerland J.M., Hengst L., Pan C.H., Alexander D., Stampfer M.R., Reed S.I. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell Biol. 14:1994;3683-3694.
29. McConnell B.B., Gregory F.J., Stott F.J., Hara E., Peters G. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2- associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell Biol. 19:1999;1981-1989. [in process citation].
30. Lucibello F.C., Sewing A., Brusselbach S., Burger C., Muller R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci. 105:1993;123-133.
31. Morisaki H., Ando A., Nagata Y., Pereira-Smith O., Smith J.R., Ikeda K., Nakanishi M. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence roles of p16, p21, and cyclin D1 . Exp. Cell Res. 253:1999;503-510.
32. Connell-Crowley L., Solomon M.J., Wei N., Harper J.W. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro. Mol. Biol. Cell. 4:1993;79-92.
33. Russo A.A., Jeffrey P.D., Pavletich N.P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3:1996;696-700.
34. Desai D., Wessling H.C., Fisher R.P., Morgan D.O. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2, Mol. Cell Biol. 15:1995;345-350.
35. Gu Y., Rosenblatt J., Morgan D.O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:1992;3995-4005.